2-Butoxyethanol Occupational Exposure Monitoring, Urine

Purpose

Occupational Exposure Monitoring for 2-Butoxyethanol Exposure

Method(s)

Colorimetry (C)

Gas Chromatography/Mass Spectrometry (GC/MS)

Suggested CPT Code(s)

82570

83921

New York State Approval Status

Approved

Turnaround Time

8 days (If Positive: 12 days)

Test Includes


1	Creatinine		Colorimetry (C)	mg/L	100	Biological Marker (Renal)
2	2-Butoxyacetic Acid - Total	2-Butoxyacetate; 2-Butoxyethanol Metabolite; BAA; Butyl Cellosolve® Metabolite; Ethylene Glycol Monobutyl Ether (EGBE) Metabolite; n-Butoxyacetic Acid; n-Butoxyethanol Metabolite	Gas Chromatography/Mass Spectrometry (GC/MS)	mcg/mL	0.5	Biological Marker (Renal)
3	2-Butoxyacetic Acid - Total (Creatinine corrected)	2-Butoxyacetate; 2-Butoxyethanol Metabolite; BAA; Butyl Cellosolve® Metabolite; Ethylene Glycol Monobutyl Ether (EGBE) Metabolite; n-Butoxyacetic Acid; n-Butoxyethanol Metabolite	Gas Chromatography/Mass Spectrometry (GC/MS)	mg/g Creat

Reflex Tests

Test Code	Test Name
6022U	Specific Gravity Confirmation, Urine

Specimen Type

Urine

Requested Volume

3 mL

Minimum Volume

1.4 mL

Special Handling

Collect sample at end of shift.

Specimen Container

Plastic container (preservative-free)

Additional Collection Instructions

Transport Temperature

Refrigerated

Light Protection

Not Required

Rejection Criteria

Received Room Temperature.

Rejection criteria pertain to clinical specimen submissions only.

Stability

Room Temperature: 5 day(s)
Refrigerated: 30 day(s)
Frozen (-20 °C): 30 day(s)


1	Creatinine		Colorimetry (C)	mg/L	100	Biological Marker (Renal)
2	2-Butoxyacetic Acid - Total	2-Butoxyacetate; 2-Butoxyethanol Metabolite; BAA; Butyl Cellosolve® Metabolite; Ethylene Glycol Monobutyl Ether (EGBE) Metabolite; n-Butoxyacetic Acid; n-Butoxyethanol Metabolite	Gas Chromatography/Mass Spectrometry (GC/MS)	mcg/mL	0.5	Biological Marker (Renal)
3	2-Butoxyacetic Acid - Total (Creatinine corrected)	2-Butoxyacetate; 2-Butoxyethanol Metabolite; BAA; Butyl Cellosolve® Metabolite; Ethylene Glycol Monobutyl Ether (EGBE) Metabolite; n-Butoxyacetic Acid; n-Butoxyethanol Metabolite	Gas Chromatography/Mass Spectrometry (GC/MS)	mg/g Creat

Example Report (Negative)

Example Report (Positive)

Interface Map

2053U 2-Butoxyethanol Occupational Exposure Monitoring, Urine - Current Version
Analyte	Units	Analyte Mapping Code	LOINC®
Creatinine	mg/L	CREAT	2161-8
2-Butoxyacetic Acid - Total	mcg/mL	BUTOXYACET	35585-9
2-Butoxyacetic Acid - Total (Creatinine corrected)	mg/g Creat	BUTOXYACCR

6022U Specific Gravity Confirmation, Urine- Current Version
Analyte	Units	Analyte Mapping Code
Specific Gravity		SPGRAVITY

LOINC^® Information

2053U 2-Butoxyethanol Occupational Exposure Monitoring, Urine - Current Version
Analyte	Units	Analyte Mapping Code	LOINC®
Creatinine	mg/L	CREAT	2161-8
2-Butoxyacetic Acid - Total	mcg/mL	BUTOXYACET	35585-9
2-Butoxyacetic Acid - Total (Creatinine corrected)	mg/g Creat	BUTOXYACCR

6022U Specific Gravity Confirmation, Urine - Current Version
Analyte	LOINC®
Specific Gravity	5810-7


Some LOINC^® codes may not have been assigned or are not available. The LOINC^® codes are copyright © 1995-2017, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. All rights reserved. Additional information can be found at LOINC.org.

The CPT Codes provided in this document are based on AMA Guidelines and are for informational purposes only. NMS Labs Does not assume responsibility for billing errors due to Reliance on the CPT Codes listed in this document.

*The information contained in this document represents database configurations, as they will appear on the effective date listed above.